{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:16:50Z","timestamp":1789676210566,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62027901, 82272062, 91959129, U21A20386, and 32271448"],"award-info":[{"award-number":["62027901, 82272062, 91959129, U21A20386, and 32271448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07326-0","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:54:07Z","timestamp":1763412847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HOXA9 drives lymphatic metastasis by activating the c-MYC-glycolysis-lactate axis in gastric cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Tailiang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-3587","authenticated-orcid":false,"given":"Yanfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"1","key":"7326_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/157488512800389164","volume":"7","author":"A Imran","year":"2012","unstructured":"Imran A, Waseem AW, Kishwar S, Ashanul H. Thalidomide: A banned drug resurged into future anticancer drug. Curr Drug Therapy. 2012;7(1):13\u201323.","journal-title":"Curr Drug Therapy"},{"issue":"20","key":"7326_CR2","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/0929867323666160405111152","volume":"23","author":"I Ali","year":"2016","unstructured":"Ali I, Lone MN, Suhail M, Mukhtar SD, Asnin L. Advances in nanocarriers for anticancer drugs delivery. Curr Med Chem. 2016;23(20):2159\u201387.","journal-title":"Curr Med Chem"},{"issue":"1","key":"7326_CR3","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"7326_CR4","doi-asserted-by":"publisher","first-page":"167773","DOI":"10.1016\/j.bbadis.2025.167773","volume":"1871","author":"B Yan","year":"2025","unstructured":"Yan B, Dong X, Wu Z, Chen D, Jiang W, Cheng J, et al. Association of proteomics with lymph node metastasis in early gastric cancer patients. Biochim Biophys Acta Mol Basis Dis. 2025;1871(5):167773.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7326_CR5","doi-asserted-by":"crossref","unstructured":"Qiu B, Zheng Y, Liu S, Song R, Wu L, Lu C et al. Multi-task deep learning based on longitudinal CT images facilitates prediction of lymph node metastasis and survival in chemotherapy-treated gastric cancer. Cancer Res. 2025.","DOI":"10.1158\/0008-5472.29457008"},{"issue":"1","key":"7326_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/157340613804488297","volume":"9","author":"I Ali","year":"2013","unstructured":"Ali I, Wani WA, Saleem K, Wesselinova D, Syntheses. DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med Chem. 2013;9(1):11\u201321.","journal-title":"Med Chem"},{"key":"7326_CR7","doi-asserted-by":"crossref","unstructured":"Ali I, Alsehli M, Scotti L, Tullius Scotti M, Tsai ST, Yu RS et al. Progress in polymeric nano-medicines for theranostic cancer treatment. Polym (Basel). 2020;12(3).","DOI":"10.3390\/polym12030598"},{"key":"7326_CR8","doi-asserted-by":"publisher","first-page":"108849","DOI":"10.1016\/j.pharmthera.2025.108849","volume":"270","author":"S Ahn","year":"2025","unstructured":"Ahn S, Kaipparettu BA. G-protein coupled receptors in metabolic reprogramming and cancer. Pharmacol Ther. 2025;270:108849.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"7326_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"key":"7326_CR10","doi-asserted-by":"publisher","first-page":"1324045","DOI":"10.3389\/fimmu.2024.1324045","volume":"15","author":"S Venkatraman","year":"2024","unstructured":"Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.","journal-title":"Front Immunol"},{"issue":"1","key":"7326_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12967-025-06474-7","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Jiang H, Pan M, Feng C, Li Y, Chen L, et al. Habitat radiomics predicts occult lymph node metastasis and uncovers immune microenvironment of head and neck cancer. J Transl Med. 2025;23(1):498.","journal-title":"J Transl Med"},{"issue":"5","key":"7326_CR12","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1245\/s10434-025-17008-2","volume":"32","author":"AS Baskin","year":"2025","unstructured":"Baskin AS, Burapachaisri K, Guha S, Velotta JB. The landmark series: advances in preoperative mediastinal lymph node staging for Non-small cell lung cancer (NSCLC). Ann Surg Oncol. 2025;32(5):3175\u201386.","journal-title":"Ann Surg Oncol"},{"key":"7326_CR13","doi-asserted-by":"publisher","first-page":"104598","DOI":"10.1016\/j.critrevonc.2024.104598","volume":"207","author":"CG Mart\u00ednez","year":"2025","unstructured":"Mart\u00ednez CG, Therapontos S, Lorente JA, Lucena MA, Ortega FG, Serrano MJ. Evaluating MicroRNAs as diagnostic tools for lymph node metastasis in breast cancer: findings from a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2025;207:104598.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"7326_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12903-023-03043-6","volume":"23","author":"K Wu","year":"2023","unstructured":"Wu K, Han N, Mao Y, Li Y. Increased levels of PD1 and Glycolysis in CD4(+) T cells are positively associated with lymph node metastasis in OSCC. BMC Oral Health. 2023;23(1):356.","journal-title":"BMC Oral Health"},{"issue":"1","key":"7326_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1874471016666230829100703","volume":"17","author":"O Kandemir","year":"2024","unstructured":"Kandemir O, Demir F. An investigation of the relationship between (18)F-FDG PET\/CT parameters of primary tumors and lymph node metastasis in resectable Non-small cell lung cancer. Curr Radiopharm. 2024;17(1):111\u20136.","journal-title":"Curr Radiopharm"},{"issue":"9","key":"7326_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12149-018-1288-2","volume":"32","author":"J Yoo","year":"2018","unstructured":"Yoo J, Kim BS, Yoon HJ. Predictive value of primary tumor parameters using (18)F-FDG PET\/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node. Ann Nucl Med. 2018;32(9):642\u20138.","journal-title":"Ann Nucl Med"},{"issue":"11","key":"7326_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/MNM.0000000000001741","volume":"44","author":"C Song","year":"2023","unstructured":"Song C, Lee JJ, Lee SH, Park JY, Kim DY, Suh DS, et al. Application of preoperative fluorodeoxyglucose-PET\/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer. Nucl Med Commun. 2023;44(11):1005\u201310.","journal-title":"Nucl Med Commun"},{"issue":"2","key":"7326_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-023-10159-2","volume":"43","author":"US Shenoy","year":"2024","unstructured":"Shenoy US, Adiga D, Alhedyan F, Kabekkodu SP, Radhakrishnan R. HOXA9 transcription factor is a double-edged sword: from development to cancer progression. Cancer Metastasis Rev. 2024;43(2):709\u201328.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"7326_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12935-022-02767-9","volume":"22","author":"L Tang","year":"2022","unstructured":"Tang L, Peng L, Tan C, Liu H, Chen P, Wang H. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential. Cancer Cell Int. 2022;22(1):349.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"7326_CR20","doi-asserted-by":"publisher","first-page":"107346","DOI":"10.1016\/j.isci.2023.107346","volume":"26","author":"Z Li","year":"2023","unstructured":"Li Z, Lu T, Chen Z, Yu X, Wang L, Shen G, et al. HOXA11 promotes lymphatic metastasis of gastric cancer via transcriptional activation of TGF\u03b21. iScience. 2023;26(8):107346.","journal-title":"iScience"},{"issue":"1","key":"7326_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","volume":"40","author":"C Song","year":"2021","unstructured":"Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis. J Exp Clin Cancer Res. 2021;40(1):62.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"7326_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/1541-7786.MCR-17-0655","volume":"16","author":"L Shao","year":"2018","unstructured":"Shao L, Chen Z, Peng D, Soutto M, Zhu S, Bates A, et al. Methylation of the HOXA10 promoter directs miR-196b-5p-Dependent cell proliferation and invasion of gastric cancer cells. Mol Cancer Res. 2018;16(4):696\u2013706.","journal-title":"Mol Cancer Res"},{"issue":"41","key":"7326_CR23","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.3748\/wjg.v19.i41.7078","volume":"19","author":"JY Lim","year":"2013","unstructured":"Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, et al. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol. 2013;19(41):7078\u201388.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"7326_CR24","first-page":"3406","volume":"26","author":"YX He","year":"2022","unstructured":"He YX, Song XH, Zhao ZY, Zhao H. HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2022;26(10):3406.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7326_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2147\/OTT.S196986","volume":"12","author":"Z Qin","year":"2019","unstructured":"Qin Z, Chen Z, Weng J, Li S, Rong Z, Zhou C. Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1\/2. Onco Targets Ther. 2019;12:1803\u201313.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"7326_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12032-013-0564-1","volume":"30","author":"Y Han","year":"2013","unstructured":"Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang HM, et al. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry. Med Oncol. 2013;30(2):564.","journal-title":"Med Oncol"},{"issue":"1","key":"7326_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12957-021-02363-7","volume":"19","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhang Q, Dong M, Yu Y. MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt\/\u03b2-cadherin pathway. World J Surg Oncol. 2021;19(1):247.","journal-title":"World J Surg Oncol"},{"issue":"9","key":"7326_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00432-024-05950-9","volume":"150","author":"G Bao","year":"2024","unstructured":"Bao G, Wei H, Yan J, Li Y, Xue C, Fu R, et al. HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2024;150(9):422.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"7326_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10120-017-0787-5","volume":"21","author":"C Ma","year":"2018","unstructured":"Ma C, Luo C, Yin H, Zhang Y, Xiong W, Zhang T, et al. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion. Gastric Cancer. 2018;21(4):617\u201331.","journal-title":"Gastric Cancer"},{"key":"7326_CR30","doi-asserted-by":"publisher","first-page":"1453482","DOI":"10.3389\/fimmu.2024.1453482","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Wang QB, Liang YB, Chen XM, Luo WL, Li YK, et al. Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis. Front Immunol. 2024;15:1453482.","journal-title":"Front Immunol"},{"issue":"1","key":"7326_CR31","doi-asserted-by":"publisher","first-page":"2320951","DOI":"10.1080\/2162402X.2024.2320951","volume":"13","author":"J Su","year":"2024","unstructured":"Su J, Mao X, Wang L, Chen Z, Wang W, Zhao C, et al. Lactate\/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer. Oncoimmunology. 2024;13(1):2320951.","journal-title":"Oncoimmunology"},{"issue":"7","key":"7326_CR32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346.","journal-title":"Int J Cancer"},{"issue":"5","key":"7326_CR33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1245\/s10434-006-9314-3","volume":"14","author":"H Saito","year":"2007","unstructured":"Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol. 2007;14(5):1688\u201393.","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"7326_CR34","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.7150\/thno.26900","volume":"8","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhao C, Zhao J, Zhu Y, Weng X, Chen Q, et al. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival. Theranostics. 2018;8(16):4359\u201371.","journal-title":"Theranostics"},{"issue":"6","key":"7326_CR35","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/1878-0261.12633","volume":"14","author":"CS Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves CS, Xavier-Magalh\u00e3es A, Martins EP, Pinto AA, Pires MM, Pinheiro C, et al. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Mol Oncol. 2020;14(6):1224\u201341.","journal-title":"Mol Oncol"},{"key":"7326_CR36","doi-asserted-by":"crossref","unstructured":"Osmond B, Facey COB, Zhang C, Boman BM. HOXA9 overexpression contributes to stem cell overpopulation that drives development and growth of colorectal cancer. Int J Mol Sci. 2022;23(12).","DOI":"10.3390\/ijms23126799"},{"key":"7326_CR37","doi-asserted-by":"publisher","first-page":"101142","DOI":"10.1016\/j.neo.2025.101142","volume":"62","author":"H Liu","year":"2025","unstructured":"Liu H, Fu Y, Tang L, Song B, Gu W, Yang H, et al. O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma. Neoplasia. 2025;62:101142.","journal-title":"Neoplasia"},{"issue":"1","key":"7326_CR38","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1038\/s41467-024-50986-7","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Q, Yu X, Lu L, Zhou Z, Li M, et al. The microprotein HDSP promotes gastric cancer progression through activating the MECOM-SPINK1-EGFR signaling axis. Nat Commun. 2024;15(1):8381.","journal-title":"Nat Commun"},{"issue":"1","key":"7326_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13059-023-03149-8","volume":"25","author":"M Zhang","year":"2024","unstructured":"Zhang M, Hyle J, Chen X, Xin Y, Jin Y, Zhang J, et al. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome Biol. 2024;25(1):16.","journal-title":"Genome Biol"},{"issue":"1","key":"7326_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-025-07645-6","volume":"16","author":"Z Lin","year":"2025","unstructured":"Lin Z, Liang F, Hong G, Jiang X, Zhang Q, Wang M. TACC3 enhances Glycolysis in bladder cancer cells through inducing acetylation of c-Myc. Cell Death Dis. 2025;16(1):311.","journal-title":"Cell Death Dis"},{"issue":"6","key":"7326_CR41","doi-asserted-by":"publisher","first-page":"130801","DOI":"10.1016\/j.bbagen.2025.130801","volume":"1869","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Wang Y, Pan D, Liu X, Gan J, Huang L, et al. USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing Glycolysis. Biochim Biophys Acta Gen Subj. 2025;1869(6):130801.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"5","key":"7326_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12032-025-02722-4","volume":"42","author":"S Bai","year":"2025","unstructured":"Bai S, Hu Y, Chen N, Zhou L, Ju W, Qiao X, et al. DCAF13 influences breast cancer chemotherapy resistance through metabolic reprogramming by regulating c-Myc expression. Med Oncol. 2025;42(5):178.","journal-title":"Med Oncol"},{"issue":"5","key":"7326_CR43","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/cas.16098","volume":"115","author":"M Nakanishi","year":"2024","unstructured":"Nakanishi M, Ibe A, Morishita K, Shinagawa K, Yamamoto Y, Takahashi H, et al. Acid-sensing receptor GPR4 plays a crucial role in lymphatic cancer metastasis. Cancer Sci. 2024;115(5):1551\u201363.","journal-title":"Cancer Sci"},{"key":"7326_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.biopha.2017.08.144","volume":"96","author":"J Yu","year":"2017","unstructured":"Yu J, Tian X, Chang J, Liu P, Zhang R. RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182\/HOXA9. Biomed Pharmacother. 2017;96:782\u201391.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"7326_CR45","first-page":"5883","volume":"14","author":"YY Ma","year":"2017","unstructured":"Ma YY, Zhang Y, Mou XZ, Liu ZC, Ru GQ, Li E. High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis. Oncol Lett. 2017;14(5):5883\u20139.","journal-title":"Oncol Lett"},{"key":"7326_CR46","doi-asserted-by":"crossref","unstructured":"Demma MJ, Mapelli C, Sun A, Bodea S, Ruprecht B, Javaid S et al. Omomyc reveals new mechanisms to inhibit the MYC oncogene. Mol Cell Biol. 2019;39(22).","DOI":"10.1128\/MCB.00248-19"},{"issue":"1","key":"7326_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-021-00595-3","volume":"6","author":"H Wu","year":"2021","unstructured":"Wu H, Wang Y, Ying M, Jin C, Li J, Hu X. Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli. Signal Transduct Target Ther. 2021;6(1):242.","journal-title":"Signal Transduct Target Ther"},{"key":"7326_CR48","doi-asserted-by":"crossref","unstructured":"Silva A, Antunes B, Batista A, Pinto-Ribeiro F, Baltazar F, Afonso J. In vivo anticancer activity of AZD3965: a systematic review. Molecules. 2021;27(1).","DOI":"10.3390\/molecules27010181"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07326-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07326-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07326-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:03:02Z","timestamp":1770984182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07326-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7326"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07326-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Southern Medical University, and written informed consent was secured from each patient prior to the collection of samples. The animal experiment protocols were approved by the Institutional Animal Care and Use Committee of Southern Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1294"}}